Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
Cash Flow Under PressureContracting
Percentile Rank20
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-27.02M
↓ 17% vs avg
Percentile
P20
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-23.11M
Historical baseline
PeriodValueYoY Change
TTM$-27.02M+28.1%
2024$-37.55M+20.8%
2023$-47.42M-46.0%
2022$-32.48M-37.8%
2021$-23.57M-29.0%
2020$-18.27M-17.3%
2019$-15.58M-66.1%
2018$-9.38M-2.1%
2017$-9.19M+13.2%
2016$-10.59M-